Quantitative.

The article discusses a study which advocates the use of proton magnetic resonance spectroscopic imaging (MRSI) to diagnose prostate cancer. However, the lack of robust quantification methods yielding reproducible results blocks the widespread use of this technique. It aims to develop a standardized and fully automated approach for quantitative prostate MRSI. It looks at the metabolic variables as potential biomarkers for prostate cancer diagnosis by correlation MRSI results.